The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Edwards Lifesciences Corp shares valued at $112,612 were sold by Chopra Daveen on May 22 ’25. At $75.08 per share, Chopra Daveen sold 1,500 shares. The insider’s holdings dropped to 33,496 shares worth approximately $2.51 million following the completion of this transaction.
Also, Chopra Daveen purchased 1,500 shares, netting a total of over 112,612 in proceeds.
Before that, Lippis Daniel J. had sold 330 shares from its account. In a trade valued at $24,560, the CVP, JAPAC traded Edwards Lifesciences Corp shares for $74.42 each. Upon closing the transaction, the insider’s holdings decreased to 330 shares, worth approximately $1.99 million.
As published in a research note from Piper Sandler on April 24, 2025, Edwards Lifesciences Corp [EW] has been rated up from a Neutral to an Overweight and the price target has been revised to $80. Analysts at Stifel upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late January. As of January 16, 2025, Wolfe Research has decreased its “Peer perform” rating to a “an Underperform” for EW. Earlier on December 16, 2024, BofA Securities upgraded its rating. Their new recommendation was “a Buy” for EW stock which previously was a “a Neutral”.
Analyzing EW Stock Performance
During the last five days, there has been a drop of approximately -2.72%. Over the course of the year, Edwards Lifesciences Corp shares have jumped approximately 1.03%. Shares of the company reached a 52-week high of $78.37 on 05/20/25 and a 52-week low of $65.94 on 04/09/25.
Support And Resistance Levels for Edwards Lifesciences Corp (EW)
According to the 24-hour chart, there is a support level at 74.26, which, if violated, would cause prices to drop to 73.74. In the upper region, resistance lies at 75.74. The next price resistance is at 76.70. RSI (Relative Strength Index) is 49.84 on the 14-day chart, showing neutral technical sentiment.
